HHPG-19K Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HHPG-19K Injection, covering 2025-08-07 to 2025-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies [Phase 3]